AAAAAA

   
Results: 1-24 |
Results: 24
Determination of cyclosporin A in human and mouse plasma by reversed-phasehigh-performance liquid chromatography
Authors: Bardelmeijer, HA Ouwehand, M Beijnen, JH Schellens, JHM van Tellingen, O
Citation: Ha. Bardelmeijer et al., Determination of cyclosporin A in human and mouse plasma by reversed-phasehigh-performance liquid chromatography, J CHROMAT B, 763(1-2), 2001, pp. 201-206
Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection
Authors: Kemper, EM Jansen, B Brouwer, KR Schellens, JHM Beijnen, JH van Tellingen, O
Citation: Em. Kemper et al., Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection, J CHROMAT B, 759(1), 2001, pp. 135-143
The effect of different doses of cyclosporin A on the systemic exposure oforally administered paclitaxel
Authors: Malingre, MM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., The effect of different doses of cyclosporin A on the systemic exposure oforally administered paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 351-358
Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry
Authors: Crul, M van den Bongard, HJGD Tibben, MM van Tellingen, O Sava, G Schellens, JHM Beijnen, JH
Citation: M. Crul et al., Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry, FRESEN J AN, 369(5), 2001, pp. 442-445
The importance of drug-transporting P-glycoproteins in toxicology
Authors: van Tellingen, O
Citation: O. Van Tellingen, The importance of drug-transporting P-glycoproteins in toxicology, TOX LETT, 120(1-3), 2001, pp. 31-41
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
Authors: Malingre, MM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A, CANC CHEMOT, 47(4), 2001, pp. 347-354
Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein
Authors: Bardelmeijer, HA Beijnen, JH Brouwer, KR Rosing, H Nooijen, WJ Schellens, JHM van Tellingen, O
Citation: Ha. Bardelmeijer et al., Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein, CLIN CANC R, 6(11), 2000, pp. 4416-4421
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients
Authors: Terwogt, JMM van Tellingen, O Panday, VRN Huizing, MT Schellens, JHM Huinink, WWT Boschma, MUS Giaccone, G Veenhof, CHN Beijnen, JH
Citation: Jmm. Terwogt et al., Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients, ANTI-CANC D, 11(9), 2000, pp. 687-694
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration
Authors: Malingre, MM Schellens, JHM van Tellingen, O Rosing, H Koopman, FJ Duchin, K Huinink, WWT Swart, M Beijnen, JH
Citation: Mm. Malingre et al., Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration, ANTI-CANC D, 11(10), 2000, pp. 813-820
Modulation of oral bioavailability of anticancer drugs: from mouse to man
Authors: Schellens, JHM Malingre, MM Kruijtzer, CMF Bardelmeijer, HA van Tellingen, O Schinkel, AH Beijnen, JH
Citation: Jhm. Schellens et al., Modulation of oral bioavailability of anticancer drugs: from mouse to man, EUR J PH SC, 12(2), 2000, pp. 103-110
Phase I and pharmacokinetic study of oral paclitaxel
Authors: Malingre, MM Terwogt, JMM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., Phase I and pharmacokinetic study of oral paclitaxel, J CL ONCOL, 18(12), 2000, pp. 2468-2475
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery
Authors: Bardelmeijer, HA van Tellingen, O Schellens, JHM Beijnen, JH
Citation: Ha. Bardelmeijer et al., The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery, INV NEW DR, 18(3), 2000, pp. 231-241
The role of MDR1A P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice
Authors: van Asperen, J van Tellingen, O Beijnen, JH
Citation: J. Van Asperen et al., The role of MDR1A P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice, DRUG META D, 28(3), 2000, pp. 264-267
Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4'-hydrazino-2-stilbazole
Authors: Sparidans, RW Kettenes-van den Bosch, JJ van Tellingen, O Nuyen, B Henrar, REC Jimeno, JM Faircloth, G Floriano, P Rinehart, KL Beijnen, JH
Citation: Rw. Sparidans et al., Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4'-hydrazino-2-stilbazole, J CHROMAT B, 729(1-2), 1999, pp. 43-53
Coadministration of oral cyclosporin a enables oral therapy with paclitaxel
Authors: Terwogt, JMM Malingre, MM Beijnen, JH Huinink, WWT Rosing, H Koopman, FJ van Tellingen, O Swart, M Schellens, JHM
Citation: Jmm. Terwogt et al., Coadministration of oral cyclosporin a enables oral therapy with paclitaxel, CLIN CANC R, 5(11), 1999, pp. 3379-3384
Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on theplasma pharmacokinetics of docetaxel and metabolites in mice
Authors: van Tellingen, O Beijnen, JH Verweij, J Scherrenburg, EJ Nooijen, WJ Sparreboom, A
Citation: O. Van Tellingen et al., Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on theplasma pharmacokinetics of docetaxel and metabolites in mice, CLIN CANC R, 5(10), 1999, pp. 2918-2924
The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts
Authors: Boven, E Jansen, WJM Hulscher, TM Beijnen, JH van Tellingen, O
Citation: E. Boven et al., The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts, EUR J CANC, 35(5), 1999, pp. 840-849
Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic study
Authors: van Gijn, R Huinink, WWT Rodenhuis, S Vermorken, JB van Tellingen, O Rosing, H van Warmerdam, LJC Beijnen, JH
Citation: R. Van Gijn et al., Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic study, ANTI-CANC D, 10(1), 1999, pp. 17-23
Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice
Authors: van Gijn, R van Tellingen, O Haverkate, E Kettenes-van den Bosch, JJ Bult, A Beijnen, JH
Citation: R. Van Gijn et al., Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice, INV NEW DR, 17(1), 1999, pp. 29-41
Comparative pharmacokinetics of vinblastine after a 96-hour continuous infusion in wild-type mice and mice lacking mdr1a P-glycoprotein
Authors: van Asperen, J van Tellingen, O Schinkel, AH Beijnen, JH
Citation: J. Van Asperen et al., Comparative pharmacokinetics of vinblastine after a 96-hour continuous infusion in wild-type mice and mice lacking mdr1a P-glycoprotein, J PHARM EXP, 289(1), 1999, pp. 329-333
Absence or pharmacological blocking of placental P-glycoprotein profoundlyincreases fetal drug exposure
Authors: Smit, JW Huisman, MT van Tellingen, O Wiltshire, HR Schinkel, AH
Citation: Jw. Smit et al., Absence or pharmacological blocking of placental P-glycoprotein profoundlyincreases fetal drug exposure, J CLIN INV, 104(10), 1999, pp. 1441-1447
Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel inpatients
Authors: van Tellingen, O Huizing, MT Panday, VRN Schellens, JHM Nooijen, WJ Beijnen, JH
Citation: O. Van Tellingen et al., Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel inpatients, BR J CANC, 81(2), 1999, pp. 330-335
Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
Authors: van Asperen, J van Tellingen, O Tijssen, F Schinkel, AH Beijnen, JH
Citation: J. Van Asperen et al., Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein, BR J CANC, 79(1), 1999, pp. 108-113
High-performance liquid chromatographic bio-analysis of PSC 833 in human and murine plasma
Authors: van Tellingen, O Kemper, M Tijssen, F van Asperen, J Nooijen, WJ Beijnen, JH
Citation: O. Van Tellingen et al., High-performance liquid chromatographic bio-analysis of PSC 833 in human and murine plasma, J CHROMAT B, 719(1-2), 1998, pp. 251-257
Risultati: 1-24 |